Latest News about REGN
Recent news which mentions REGN
From Benzinga
From Benzinga
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
April 11, 2025
From Benzinga
Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline
April 09, 2025
From Benzinga
From Motley Fool
From Motley Fool
Vertex, Alnylam Best Positioned As Biopharma Braces For Tariff Impact, Goldman Sachs Flags Regeneron, Biogen Risks
April 04, 2025
From Benzinga
From Benzinga
Sensei Biotherapeutics Reports Favorable Initial Clinical Activity Data For Solnerstotug In Resistant Tumors
March 28, 2025
From Benzinga
Why Pharma and Biotech Stocks Got Thrashed on Tuesday
March 25, 2025
From Motley Fool
Unity Biotechnology Unveils Mixed Data From Study For Diabetes-Related Blindness, Stock Falls
March 24, 2025
From Benzinga
From Benzinga
Price Over Earnings Overview: Regeneron Pharmaceuticals
March 18, 2025
From Benzinga
From Benzinga
From Benzinga
Tickers
REGN
From Motley Fool
Eli Lilly's Single Monthly Maintenance Shot Of Eczema Drug Shows Completely Clear Skin At 3 Years In 50% Of Trial Patients
March 07, 2025
From Benzinga
Apogee Therapeutics' Investigational Atopic Dermatitis Potential Shows Strong Tolerability, Extended Half-Life in Early Trial
March 03, 2025
From Benzinga
Regeneron Touts Encouraging Early Data From Investigational Gene Therapy For Rare Form Of Hearing Loss
February 25, 2025
From Benzinga
Price Over Earnings Overview: Regeneron Pharmaceuticals
February 21, 2025
From Benzinga
This Company Just Initiated a Quarterly Dividend: Time to Buy?
February 18, 2025
Tickers
REGN
From Motley Fool
Looking Into Regeneron Pharmaceuticals's Recent Short Interest
February 17, 2025
Tickers
REGN
From Benzinga
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years
February 14, 2025
From Benzinga
Eye Disease Focused 4D Molecular Therapeutics Lays Out 52-Week Results From Wet AMD Study
February 10, 2025
From Benzinga
Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move
February 10, 2025
From Motley Fool
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years
February 07, 2025
From Benzinga
Why Regeneron Pharmaceuticals Stock Topped the Market on Tuesday
February 04, 2025
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.